Image via Endpoints News
Last updated
Vertex Pharmaceuticals: Product Launch
Vertex's sickle cell gene therapy Casgevy received regulatory approval for pediatric use, now cleared to treat sickle cell disease with recurrent vaso-occlusive crises and transfusion-dependent β-thalassemia in children.
Source: Endpoints News
The leadership read
Product momentum tends to widen healthcare product and commercial leadership bench strength.
Market context: This lands while the Talent Market Index reads 111.4 (Hot) — up 5.2 versus the prior month — and Americas signal share is rising (+6.3pts).
Vertex Pharmaceuticals: 2 signals in the last 90 days; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 20 days.
MitchelLake in this thematic
Our work · 2018
RPO (40+ roles)
One Medical Group
Americas · Healthtech · healthtech · primary care
Our work · 2017
Retained Search
Healthengine
Oceania · Healthtech · healthtech · digital health
Our work · 2016
Retained Search
The Health Consultancy Pty Ltd
Oceania · Healthtech · healthtech · healthcare consulting
Also at Vertex Pharmaceuticals →
More signals across Healthcare
Leadership Change · Americas
Alkermes →Blair Jackson has joined Alkermes as incoming CEO with an explicit strategy to compete in the orexin drug market against larger competitors like Eli Lilly and Takeda. Jackson signals the next 12 months are critical for the company's competitive positioning.
Strategic Hiring · Americas
United States Air Force →USAF exploring replacement for B-52 bombers as costs skyrocket on upgrades
Ma Activity · Americas
Apellis Pharmaceuticals →Apellis Pharmaceuticals was acquired by Biogen for $5.6 billion, indicating major integration and potential restructuring
Restructuring · EMEA
Ramsay Health Care →Ramsay Health Care (ASX:RHC) is undergoing a European restructure to unlock additional shareholder value. The article headline suggests this is a strategic operational realignment, though specific details are not provided in the document excerpt.
Leadership Change · Asia
Takeda →Takeda appointed first female CEO who is prioritizing AI integration across biopharma business operations
Ma Activity · EMEA
King's College London →King's College London announced plans to merge with Cranfield University in 2027
Intelligence powered by Autonodal ↗